glp-1 drugs shortage FDA says that the is over How GLP-1 drugs are used
Description
95% CI, -0.02 to 0.03

Noticing hair thinning during GLP-1 weight loss

Beyond these metabolic benefits, accumulating evidence indicates that GLP-1RAs exert immunomodulatory effects, including suppression of pro-inflammatory cytokines, enhancement of regulatory T-cell function, and improvements in adipose tissue and gut-derived immune signaling

Interested in weight loss injections such as Saxenda or Wegovy
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

Read the full article covered by Nutritional Outlook here:
